Reulay

Reulay, a digital health startup, was founded by leading psychiatrists, neuroscientists, and AI researchers with the mission to enhance the quality of life and longevity for 2 billion people. The company focuses on creating effective, scalable, and affordable digital health therapeutics aimed at improving mental wellbeing. Their core products include personalized therapies designed to boost focus, reduce stress, and prevent burnout, leveraging neuroscience-backed solutions to address global mental health challenges.

Reulay has garnered attention from notable figures in the fields of psychiatry, neuroscience, and artificial intelligence. The startup has achieved significant milestones in developing research-backed digital therapeutics that are accessible and impactful. By prioritizing mental health and wellbeing, Reulay is making a substantial impact on the global healthcare landscape, offering innovative solutions that cater to a wide audience in need of mental health support.